Detalhe da pesquisa
1.
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial.
Eur Respir J
; 41(3): 556-64, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22700844
2.
Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
Eur J Health Econ
; 10(3): 309-21, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19101743
3.
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).
Patient
; 11(1): 131-141, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29178024
4.
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer.
J Thorac Oncol
; 10(6): 883-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25933111
5.
The economic burden of head and neck cancer: a systematic literature review.
Pharmacoeconomics
; 32(9): 865-82, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24842794
6.
The humanistic burden of head and neck cancer: a systematic literature review.
Pharmacoeconomics
; 32(12): 1213-29, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145800
7.
Afatinib in the treatment of EGFR mutation-positive NSCLC--a network meta-analysis.
Lung Cancer
; 85(2): 230-8, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24929780
8.
Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations.
J Clin Oncol
; 31(27): 3342-50, 2013 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816967
9.
Health-related quality of life and utility in patients with advanced non-small-cell lung cancer: a prospective cross-sectional patient survey in a real-world setting.
J Thorac Oncol
; 8(8): 997-1003, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23787802